Results for tag: "Hemorrhagic Fever Drug"

Hemorrhagic Fever Drugs are a class of drugs used to treat a variety of infectious diseases, including Ebola, Marburg, Lassa, and Yellow Fever. These drugs are used to reduce the severity of symptoms, reduce the risk of transmission, and improve the overall prognosis of the disease. They are typically administered intravenously or orally, and may be used in combination with other treatments. Common side effects of these drugs include nausea, vomiting, and diarrhea. The Hemorrhagic Fever Drug market is a rapidly growing sector of the Infectious Diseases Drugs market. This is due to the increasing prevalence of these diseases, as well as the need for effective treatments. As a result, many pharmaceutical companies have developed drugs to treat these diseases, and are actively researching new treatments. Some of the companies in the Hemorrhagic Fever Drug market include Gilead Sciences, Merck, Johnson & Johnson, GlaxoSmithKline, and Novartis. Show Less Read more